Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs.
BACKGROUND: Better control of diabetes mellitus reduces microvascular complications, but has limited effect on macrovascular complications including cardiovascular mortality. A spate of controversial reports has shown that some new oral antidiabetic drugs..... Read More